Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5198a2a21392d6cbc0bb4898b3fb3d29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ead90443277482e25bf91bfddef2b5a7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06 |
filingDate |
1997-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1999-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fb8ead0052957e6d6ff93e587997a1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acdb3e6ebd02f5709f343f164bfa0246 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e70b01668537dd44e856185be4248733 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1914dc3e034b52216e150032226669b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea5cf7ef44720a281548e78567a09ab3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b1d178bd193053fa06f71974238839f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c3405e101e85e12eb7336185b6b5c2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71d6ce3215eee69d345cf5f0bf903cf9 |
publicationDate |
1999-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5866592-A |
titleOfInvention |
Fibrinogen receptor antagonist and pharmaceutical compositions comprising the same |
abstract |
Compounds of the following general formula (I) and pharmaceutically acceptable salts thereof. <IMAGE> [I] |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021230586-A1 |
priorityDate |
1994-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |